Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + Paclitaxel/Carboplatin in Advanced Melanoma
NCT00111007Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of sorafenib in melanoma, sponsored by Bayer. Started May 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00111007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111007.